MINI FUTURE LONG - BIOGEN IDEC | Market Closed - Börse Stuttgart 03:53:34 2024-06-28 pm EDT | ||
| 9.72 EUR | +1.89% |
|
| Current month | +7.28% | ||
| 1 month | +14.89% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 9.72 | +1.89% |
| 24-06-27 | 9.54 | +5.30% |
| 24-06-26 | 9.06 | +0.55% |
| 24-06-25 | 9.01 | -3.22% |
| 24-06-24 | 9.31 | +2.53% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 03:53 pm EDT
More quotesStatic data
| Product type | Warrant Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MC0V5D |
| ISIN | DE000MC0V5D3 |
| Date issued | 2019-03-26 |
| Strike | 126.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 10.96 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 26.11 € |
|---|---|
| Lowest since issue | 6.1 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
231.8
USD
Average target price
283.2
USD
Spread / Average Target
+22.14%
- Stock Market
- Certificates
- Certificat
